MISSION CREEK CAPITAL PARTNERS, INC. – Novo Nordisk A/S Transaction History
MISSION CREEK CAPITAL PARTNERS, INC. portfolio value:
$579,000
portfolio value
MISSION CREEK CAPITAL PARTNERS, INC. quarter portfolio value change:
-10.59%
quarter
Novo Nordisk A/S 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.69% | -100 shares | -80K | $99.63 | 5.81K |
Q2 2022 | share | 0.00% | 0 shares | 3K | $111.43 | 5.91K | |
Q1 2022 | share | 0.00% | 0 shares | -6K | $111.05 | 5.91K | |
Q4 2021 | share | Decrease | -3.27% | -200 shares | 75K | $111.45 | 5.91K |
Q3 2021 | share | Decrease | -3.78% | -240 shares | 55K | $96.01 | 6.11K |
Q2 2021 | share | Decrease | -1.55% | -100 shares | 97K | $83.32 | 6.35K |
Q1 2021 | share | 0.00% | 0 shares | -16K | $67.06 | 6.45K | |
Q4 2020 | share | 0.00% | 0 shares | 3K | $68.52 | 6.45K | |
Q3 2020 | share | Decrease | -1.10% | -72 shares | 21K | $68.1 | 6.45K |
Q2 2020 | share | Decrease | -6.79% | -475 shares | 6K | $63.73 | 6.52K |
Q1 2020 | share | Decrease | -1.41% | -100 shares | 10K | $58.59 | 6.99K |
Q4 2019 | share | Increase | 0.00% | 7.09K shares | 411K | $55.56 | 7.09K |